Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes
- PMID: 38626182
- PMCID: PMC11747753
- DOI: 10.1210/clinem/dgae266
Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes
Abstract
Context: Patients with younger onset of type 2 diabetes (YT2D) have increased risk for kidney failure compared to those with late onset. However, the mechanism of diabetic kidney disease (DKD) progression in this high-risk group is poorly understood.
Objective: This work aimed to identify novel biomarkers and potential causal proteins associated with DKD progression in patients with YT2D.
Methods: Among YT2D (T2D onset age <40 years), 144 DKD progressors (cases) were matched for T2D onset age, sex, and ethnicity with 292 nonprogressors (controls) and divided into discovery and validation sets. DKD progression was defined as decline of estimated glomerular filtration rate (eGFR) of 3 mL/min/1.73 m2 or greater or 40% decline in eGFR from baseline. A total of 1472 plasma proteins were measured through a multiplex immunoassay that uses a proximity extension assay technology. Multivariable logistic regression was used to identify proteins associated with DKD progression. Mendelian randomization (MR) was used to evaluate causal relationship between plasma proteins and DKD progression.
Results: Forty-two plasma proteins were associated with DKD progression, independent of traditional cardiorenal risk factors, baseline eGFR, and urine albumin-to-creatinine ratio. The proteins identified were related to inflammatory and remodeling biological processes. Our findings suggest angiogenin as one of the top signals (odds ratio = 5.29; 95% CI, 2.39-11.73; P = 4.03 × 10-5). Furthermore, genetically determined plasma angiogenin level was associated with increased odds of DKD progression.
Conclusion: Large-scale proteomic analysis identified novel proteomic biomarkers for DKD progression in YT2D. Genetic evidence suggest a causal role of plasma angiogenin in DKD progression.
Keywords: diabetes kidney disease; proteomics; younger onset of type 2 diabetes.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.
Figures
Comment in
-
All Three in One: A Cohort, Proteomics, and Mendelian Randomization Biomarker Study.J Clin Endocrinol Metab. 2025 Jan 21;110(2):e544-e545. doi: 10.1210/clinem/dgae359. J Clin Endocrinol Metab. 2025. PMID: 38776236 No abstract available.
References
-
- Magliano DJ, Sacre JW, Harding JL, Gregg EW, Zimmet PZ, Shaw JE. Young-onset type 2 diabetes mellitus—implications for morbidity and mortality. Nat Rev Endocrinol. 2020;16(6):321‐331. - PubMed
-
- Liu JJ, Liu S, Gurung RL, et al. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study. Nephrol Dial Transplant. 2020;35(1):115‐121. - PubMed
-
- Song SH. Emerging type 2 diabetes in young adults. Adv Exp Med Biol. 2012;771:51‐61. - PubMed
-
- Wu H, Lau ESH, Yang A, et al. Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease: a prospective cohort study. Diabetologia. 2021;64(9):1990‐2000. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
